Japan’s Daiichi Sankyo, Merck announce US$22 billion cancer drug deal
SHARES in Japan’s Daiichi Sankyo soared today after the pharma group announced a cancer drug deal with Merck worth up to US$22 (RM105.5) billion.
Under the agreement announced by both firms, US giant Merck will pay Daiichi for the rights to three cancer drugs in development…
Read More
0
